EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal Adenocarcinomas

Margaret A Park, Kristyn Gumpper-Fedus, Somashekar G Krishna iD, Maria C Genilo-Delgado, Stephen Brantley, Phil A Hart, Mary E Dillhoff, Maria F Gomez, Toni L Basinski, Shaffer R Mok, Anjuli K Luthra, Jason B Fleming und 10 weitere

International Journal of Molecular Sciences · 07.12.2024 · 25 (23) · 13164

DOI: 10.3390/ijms252313164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.12.2024. Verfasst von Margaret A Park und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal (GI) Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Pancreatic Intraductal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, ORIEN New Oncology Visionary Award, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intraductal papillary mucinous neoplasms (IPMN) are commonly detected pancreatic cysts that may transform into pancreatic ductal adenocarcinoma (PDAC). Predicting which IPMNs will progress to PDAC remains a clinical challenge. Moreover, identifying those clinically evident IPMNs for which a surveillance approach is best is a dire clinical need. Therefore, we aimed to identify molecular signatures that distinguished between PDAC with and without clinical evidence of an IPMN to identify novel molecular pathways related to IPMN-derived PDAC that could help guide biomarker development. Data from the Oncology Research Information Exchange Network (ORIEN) multi-institute sequencing project were utilized to analyze 66 PDAC cases from Moffitt Cancer Center and The Ohio State University Wexner Medical Center, for which tumor whole transcriptome sequencing datasets were generated. Cases were classified based on whether a tumor had originated from an IPMN (n = 16) or presumably through the pancreatic intraepithelial neoplasia (PanIN) pathway (n = 50). We then performed differential expression and pathway analysis using Gene-Set Enrichment Analysis (GSEA) and Pathway Analysis with Down-weighted Genes (PADOG) algorithms. We also analyzed immune profiles using the Tumor-Immune Microenvironment Deconvolution web portal for Bulk Transcriptomics (TIMEx). Both GSEA and TIMEx indicate that PanIN-derived PDAC tumors enrich inflammatory pathways (complement, hedgehog signaling, coagulation, inflammatory response, apical surface, IL-2/STAT5, IL-6/STAT3, EMT, KRAS signaling, apical junction, IFN-gamma, allograft rejection) and are comparatively richer in almost all immune cell types than those from IPMN-derived PDAC. IPMN-derived tumors were enriched for metabolic and energy-generating pathways (oxidative phosphorylation, unfolded protein response, pancreas beta cells, adipogenesis, fatty acid metabolism, protein secretion), and the most significantly upregulated genes (padj < 0.001) included mucin 2 (MUC2) and gastrokine-2 (GKN2). Further, the metabolic-linked gene signature enriched in the IPMN-derived samples is associated with a cluster of early-stage and long-survival (top 4th quartile) PDAC cases from The Cancer Genome Atlas (TCGA) expression database. Our data suggest that IPMN-derived and PanIN-derived PDACs differ in the expression of immune profiles and metabolic pathways. These initial findings warrant validation and follow-up to develop biomarker-based strategies for early PDAC detection and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsPancreatic Intraductal NeoplasmsHumansMaleFemaleGene Expression Regulation, NeoplasticBiomarkers, TumorTumor MicroenvironmentMiddle AgedAgedGene Expression ProfilingTranscriptomeSignal Transduction

Stichwörter der Autor:innen

IPMNPanINpancreatic ductal adenocarcinomatranscriptomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastrointestinal (GI) Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Department of Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Department of Surgery, Division of Surgical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
  • Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL 33612, USA.

ORCID-Profile: Somashekar G Krishna, Aleksandra Karolak, Dung-Tsa Chen, Paul A Stewart, Jamie K Teer, Zobeida Cruz-Monserrate, Jennifer B Permuth

Förderung

  • NCI NIH HHS
  • ORIEN New Oncology Visionary Award
  • NIH HHS
  • National Cancer Institute of the National Institutes of Health
  • H. Lee Moffitt Cancer Center and Research Institute
  • The Ohio State University Comprehensive Cancer Center and the National Institutes of Health

Zitieren

APA

Park, M. A., Gumpper-Fedus, K., Krishna, S. G., Genilo-Delgado, M. C., Brantley, S., Hart, P. A., Dillhoff, M. E., Gomez, M. F., Basinski, T. L., Mok, S. R., Luthra, A. K., Fleming, J. B., Mohammadi, A., Centeno, B. A., Jiang, K., Karolak, A., Jeong, D., Chen, D. T., Stewart, P. A., …, & Permuth, J. B. (2024). Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal Adenocarcinomas. International Journal of Molecular Sciences, 25(23), 13164. https://doi.org/10.3390/ijms252313164

Vancouver

Park MA, Gumpper-Fedus K, Krishna SG, Genilo-Delgado MC, Brantley S, Hart PA, et al. Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal Adenocarcinomas. International Journal of Molecular Sciences. 2024;25(23):13164. doi:10.3390/ijms252313164

BibTeX
@article{Park2024,
  author = {Park, Margaret A and Gumpper-Fedus, Kristyn and Krishna, Somashekar G and Genilo-Delgado, Maria C and Brantley, Stephen and Hart, Phil A and Dillhoff, Mary E and Gomez, Maria F and Basinski, Toni L and Mok, Shaffer R and Luthra, Anjuli K and Fleming, Jason B and Mohammadi, Amir and Centeno, Barbara A and Jiang, Kun and Karolak, Aleksandra and Jeong, Daniel and Chen, Dung-Tsa and Stewart, Paul A and Teer, Jamie K and Cruz-Monserrate, Zobeida and Permuth, Jennifer B},
  title = {Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal Adenocarcinomas},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {23},
  pages = {13164},
  doi = {10.3390/ijms252313164}
}
Kostenlos starten →